Vident Investment Advisory, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 55 filers reported holding CASI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$85,000
-35.6%
54,8290.0%0.00%
-25.0%
Q1 2021$132,000
-50.4%
54,829
-39.3%
0.00%
-63.6%
Q4 2020$266,000
+91.4%
90,332
-0.4%
0.01%
+57.1%
Q3 2020$139,000
-17.8%
90,703
+34.3%
0.01%
-22.2%
Q2 2020$169,000
-3.4%
67,540
-21.1%
0.01%
-18.2%
Q1 2020$175,000
-17.1%
85,568
+25.1%
0.01%
-15.4%
Q4 2019$211,000
+30.2%
68,414
+41.3%
0.01%
-7.1%
Q3 2019$162,000
+125.0%
48,415
+113.7%
0.01%
+133.3%
Q2 2019$72,000
+10.8%
22,6520.0%0.01%
+50.0%
Q1 2019$65,00022,6520.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders